Halozyme Therapeutics logo
Halozyme Therapeutics HALO
$ 98.66 1.34%
report update icon

Quarterly report 2026-Q2
added 08-06-2026

Halozyme Therapeutics Cash Conversion Cycle | HALO

Annual Cash Conversion Cycle Halozyme Therapeutics

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
322 377 290 240 289 451 294 740 -7.31 160 150 99 238 268 -9.88 K 31.2 - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
740 -9.88 K -371

Quarterly Cash Conversion Cycle Halozyme Therapeutics

2026-Q2 2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - 360 389 363 - 319 423 534 - 285 287 343 - 257 268 363 - 366 302 387 73.3 1.1 K 1.1 K 927 101 211 1.25 K 479 45.5 2.81 K 2.1 K 312 10.7 31.7 59.8 58.4 36.7 44.9 42.9 51.6 75.8 142 68.2 102 27.5 57.2 45.4 69.6 66.4 51.8 57.4 95.6 65.8 269 185 110 85.6 9 8.9 -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
2.81 K 8.9 328

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer Cash Conversion Cycle Price % 24h Market Cap Country
FSD Pharma FSD Pharma
HUGE
3.11 K - 5743.5 % $ 69.7 M canadaCanada
Qilian International Holding Group Limited Qilian International Holding Group Limited
QLI
111 - -6.08 % $ 184 M chinaChina
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
-3.12 K - 1.35 % $ 17.8 M chinaChina
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
459 - - $ 2.02 B usaUSA
BioXcel Therapeutics BioXcel Therapeutics
BTAI
-32.5 K $ 1.19 5.31 % $ 14.5 M usaUSA
I-Mab I-Mab
IMAB
-4.85 K - - $ 866 M chinaChina
BeyondSpring BeyondSpring
BYSI
-37.6 $ 0.84 34.27 % $ 34.5 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
12.8 - - $ 40.3 B usaUSA
Cerus Corporation Cerus Corporation
CERS
47 $ 2.98 4.93 % $ 568 M usaUSA
Compugen Ltd. Compugen Ltd.
CGEN
-82.7 $ 2.41 4.17 % $ 225 M israelIsrael
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
17 - -1.52 % $ 24.7 M usaUSA
Завод ДИОД Завод ДИОД
DIOD
-32.7 - - - russiaRussia
Midatech Pharma plc Midatech Pharma plc
MTP
82.8 - -18.52 % $ 27.3 M britainBritain
Champions Oncology Champions Oncology
CSBR
9.02 $ 5.1 2.63 % $ 70.5 M usaUSA
Affimed N.V. Affimed N.V.
AFMD
31.4 - -34.95 % $ 21.5 M germanyGermany
AnPac Bio-Medical Science Co., Ltd. AnPac Bio-Medical Science Co., Ltd.
ANPC
-85.7 - -1.58 % $ 28.1 M chinaChina
Celyad Oncology SA Celyad Oncology SA
CYAD
-55.7 K - - $ 12.5 M belgiumBelgium
Generation Bio Co. Generation Bio Co.
GBIO
47.6 - - $ 344 M usaUSA
AnaptysBio AnaptysBio
ANAB
58 $ 58.47 4.37 % $ 1.68 B usaUSA
Anika Therapeutics Anika Therapeutics
ANIK
192 $ 21.5 1.56 % $ 308 M usaUSA
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
-1.6 K - -4.36 % $ 27 M usaUSA
Aurinia Pharmaceuticals Aurinia Pharmaceuticals
AUPH
612 $ 15.47 1.91 % $ 2.08 B canadaCanada
GlycoMimetics GlycoMimetics
GLYC
303 - 9357.83 % $ 1.01 B usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
-34.3 K - 5.93 % $ 314 M canadaCanada
BeiGene, Ltd. BeiGene, Ltd.
BGNE
52.6 - 0.49 % $ 251 B cayman-islandsCayman-islands
Bicycle Therapeutics plc Bicycle Therapeutics plc
BCYC
13.8 $ 3.9 0.24 % $ 270 M britainBritain
AIkido Pharma AIkido Pharma
AIKI
-1.92 - 1.93 % $ 17.4 M usaUSA
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
733 $ 67.36 0.99 % $ 12.9 B usaUSA